Cargando…

Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis

BACKGROUND: Metabolites are genetically and environmentally determined. Consequently, they can be used to characterize environmental exposures and reveal biochemical mechanisms that link exposure to disease. To explore disease susceptibility and improve population risk stratification, we aimed to id...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santaolalla, Aida, Garmo, Hans, Grigoriadis, Anita, Ghuman, Sundeep, Hammar, Niklas, Jungner, Ingmar, Walldius, Göran, Lambe, Mats, Holmberg, Lars, Van Hemelrijck, Mieke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651931/ https://www.ncbi.nlm.nih.gov/pubmed/31337337 http://dx.doi.org/10.1186/s12860-019-0210-7

Ejemplares similares

Serum inflammatory markers and colorectal cancer risk and survival
por: Ghuman, Sundeep, et al.
Publicado: (2017)

Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
por: Melvin, Jennifer C, et al.
Publicado: (2017)

Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study
por: Wulaningsih, Wahyu, et al.
Publicado: (2013)

Serum lactate dehydrogenase and survival following cancer diagnosis
por: Wulaningsih, Wahyu, et al.
Publicado: (2015)

Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study
por: Yiu, Andrew, et al.
Publicado: (2017)

Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study
por: Wulaningsih, Wahyu, et al.
Publicado: (2012)

Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort
por: Shackshaft, Lydia, et al.
Publicado: (2017)

Serum Glucose and Fructosamine in Relation to Risk of Cancer
por: Wulaningsih, Wahyu, et al.
Publicado: (2013)

Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum
por: Ghoshal, Arunangshu, et al.
Publicado: (2017)

Inorganic phosphate and the risk of cancer in the Swedish AMORIS study
por: Wulaningsih, Wahyu, et al.
Publicado: (2013)

Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort
por: Bosco, Cecilia, et al.
Publicado: (2018)

Serum biomarkers to predict risk of testicular and penile cancer in AMORIS
por: Ghoshal, Arunangshu, et al.
Publicado: (2017)

Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
por: Arthur, Rhonda, et al.
Publicado: (2016)

Iron metabolism and risk of cancer in the Swedish AMORIS study
por: Gaur, Anjali, et al.
Publicado: (2013)

Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis
por: Wulaningsih, Wahyu, et al.
Publicado: (2015)

Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival
por: Wulaningsih, Wahyu, et al.
Publicado: (2016)

Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies
por: Wulaningsih, Wahyu, et al.
Publicado: (2016)

Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?
por: Ghoshal, Arunangshu, et al.
Publicado: (2018)

Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study
por: Sollie, Sam, et al.
Publicado: (2019)

Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study
por: Sollie, Sam, et al.
Publicado: (2020)

Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study
por: Santaolalla, Aida, et al.
Publicado: (2021)

Fructosamine Is a Useful Indicator of Hyperglycaemia and Glucose Control in Clinical and Epidemiological Studies – Cross-Sectional and Longitudinal Experience from the AMORIS Cohort
por: Malmström, Håkan, et al.
Publicado: (2014)

Serum Total Bilirubin and Risk of Cancer: A Swedish Cohort Study and Meta-Analysis
por: Monroy-Iglesias, Maria J., et al.
Publicado: (2021)

Serum IgG Is Associated With Risk of Melanoma in the Swedish AMORIS Study
por: Kessler, Anna, et al.
Publicado: (2019)

Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
por: Van Hemelrijck, Mieke, et al.
Publicado: (2010)

Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels – The AMORIS study
por: Ivert, Torbjörn, et al.
Publicado: (2018)

Mortality following Hip Fracture in Men with Prostate Cancer
por: Van Hemelrijck, Mieke, et al.
Publicado: (2013)

Causes of death in men with localized prostate cancer: a nationwide, population‐based study
por: Van Hemelrijck, Mieke, et al.
Publicado: (2015)

Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males
por: Van Hemelrijck, Mieke, et al.
Publicado: (2022)

Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer
por: Nowinski, Salpie, et al.
Publicado: (2018)

Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure
por: Lind, Viktor, et al.
Publicado: (2021)

Improved prediction of 10‐year risk of severe liver disease in the general population using commonly available biomarkers
por: Hagström, Hannes, et al.
Publicado: (2022)

Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study
por: Parker, Jonathan, et al.
Publicado: (2020)

How to model temporal changes in comorbidity for cancer patients using prospective cohort data
por: Lindhagen, Lars, et al.
Publicado: (2015)

How to measure temporal changes in care pathways for chronic diseases using health care registry data
por: Ventimiglia, Eugenio, et al.
Publicado: (2019)

Prospective study of Type 2 diabetes mellitus, anti‐diabetic drugs and risk of prostate cancer
por: Häggström, Christel, et al.
Publicado: (2016)

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
por: Crawley, Danielle, et al.
Publicado: (2016)

Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study
por: Crawley, Danielle, et al.
Publicado: (2018)

Heterogeneity in risk of prostate cancer: A Swedish population‐based cohort study of competing risks and Type 2 diabetes mellitus
por: Häggström, Christel, et al.
Publicado: (2018)

Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study
por: Beckmann, Kerri, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_663jj2j7vbua985osscnrnc7ri